Direct sales are predicted to lead distribution channel at 47.0% share in 2026, followed by hospitals as anticipated to secure 42.0% share of end user in 2026. Adoption reflects validated dose calculation and documented treatment transfer across specialist oncology programs.
Brachytherapy Treatment Planning Systems Market Analysis By ApplicationBrachytherapy Treatment Planning Systems Market Analysis By Distribution ChannelBrachytherapy Treatment Planning Systems Market Analysis By End UserBrachytherapy Treatment Planning Systems Market Analysis By TechnologyBrachytherapy Treatment Planning Systems Market Breakdown By Product Type, Application, And Region